Neuroinflammation and Alzheimer's disease: a machine learning approach to CSF proteomics

L Gaetani, G Bellomo, L Parnetti, K Blennow… - Cells, 2021 - mdpi.com
In Alzheimer's disease (AD), the contribution of pathophysiological mechanisms other than
amyloidosis and tauopathy is now widely recognized, although not clearly quantifiable by …

Large-scale proteomic analysis of human brain identifies proteins associated with cognitive trajectory in advanced age

AP Wingo, EB Dammer, MS Breen, BA Logsdon… - Nature …, 2019 - nature.com
In advanced age, some individuals maintain a stable cognitive trajectory while others
experience a rapid decline. Such variation in cognitive trajectory is only partially explained …

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer's disease

C Depp, T Sun, AO Sasmita, L Spieth, SA Berghoff… - Nature, 2023 - nature.com
The incidence of Alzheimer's disease (AD), the leading cause of dementia, increases rapidly
with age, but why age constitutes the main risk factor is still poorly understood. Brain ageing …

Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers

L Brase, SF You, R D'Oliveira Albanus… - Nature …, 2023 - nature.com
Genetic studies of Alzheimer disease (AD) have prioritized variants in genes related to the
amyloid cascade, lipid metabolism, and neuroimmune modulation. However, the cell …

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease

B Bellaver, G Povala, PCL Ferreira, JP Ferrari-Souza… - Nature medicine, 2023 - nature.com
An unresolved question for the understanding of Alzheimer's disease (AD) pathophysiology
is why a significant percentage of amyloid-β (Aβ)-positive cognitively unimpaired (CU) …

Pulse-chase proteomics of the App knockin mouse models of Alzheimer's disease reveals that synaptic dysfunction originates in presynaptic terminals

TJ Hark, NR Rao, C Castillon, T Basta, S Smukowski… - Cell systems, 2021 - cell.com
Compromised protein homeostasis underlies accumulation of plaques and tangles in
Alzheimer's disease (AD). To observe protein turnover at early stages of amyloid beta (Aβ) …

Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders

C Yang, FHG Farias, L Ibanez, A Suhy, B Sadler… - Nature …, 2021 - nature.com
Understanding the tissue-specific genetic controls of protein levels is essential to uncover
mechanisms of post-transcriptional gene regulation. In this study, we generated a genomic …

Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations

JM Ringman, H Schulman, C Becker… - Archives of …, 2012 - jamanetwork.com
Objective To identify cerebrospinal fluid (CSF) protein changes in persons who will develop
familial Alzheimer disease (FAD) due to PSEN1 and APP mutations, using unbiased …

CSF tau microtubule-binding region identifies pathological changes in primary tauopathies

K Horie, NR Barthélemy, S Spina, L VandeVrede… - Nature medicine, 2022 - nature.com
Despite recent advances in fluid biomarker research in Alzheimer's disease (AD), there are
no fluid biomarkers or imaging tracers with utility for diagnosis and/or theragnosis available …

Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease

NA Twine, K Janitz, MR Wilkins, M Janitz - PloS one, 2011 - journals.plos.org
Recent studies strongly indicate that aberrations in the control of gene expression might
contribute to the initiation and progression of Alzheimer's disease (AD). In particular …